Menu
A screenshot of an Office of Management and Budget website page.
HHS on Feb. 6 submitted a "prerule" for regulatory review, titled "340B Drug Pricing Program Manufacturer Rebate Models."

News Alert

HHS Lays Regulatory Groundwork for Potential New 340B Rebate Rule

William Newton, Associate Editor/Senior Writer 340B Report Views
Just one day after formally withdrawing its controversial 340B rebate model pilot that had been blocked by federal courts, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

HHS Formally Withdraws 340B Rebate Pilot, Agrees to New Guardrails for Any Future Rebate Efforts

5th Circuit Unanimously Upholds Louisiana’s 340B Contract Pharmacy Access Law

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live